» Articles » PMID: 37921666

Adverse Pregnancy Outcomes and Renal-vascular Function in the Early Years After Delivery

Abstract

Adverse pregnancy outcomes (APOs: hypertensive disorders, gestational diabetes, preterm birth, and placental disorders) are associated with cardiovascular disease risk or blood volume abnormalities. Traditional risk factors might not identify highest risk people in the early years after APO deliveries. Test the hypothesis that vascular function is worse, and plasma volume-regulating renal hormones are lower after delivery in people who did versus did not have an APO. Adult participants 6 mo-3 years postdelivery of a singleton infant participated in this cross-sectional study. Exclusion criteria included current smoking, current use of certain medications, and diabetes outside of pregnancy. Differences in measurements between participants with versus without APOs were determined with tests or Wilcoxon tests. Associations of renal hormones with APO history were assessed with linear regression, adjusted for age, race, body mass index (BMI), and sodium consumption. Of 86 participants, 38 (44%) had an APO history. Those with APOs were more likely to identify as Black and had a higher BMI, 34.0 kg/m [interquartile range (IQR), 24.6, 39.3] versus 24.2 kg/m [IQR, 21.2, 31.3], < 0.05. Most brachial and all aortic blood pressures were higher in those with APOs: median aortic blood pressure was 102/74 versus 96/68 mmHg, ≤ 0.05. There were no differences in arterial stiffness or endothelial function between groups. Aldosterone was lower (54 [IQR, 28-84] vs. 80 [IQR, 39-150] pmol/L) in participants with past APOs. Blood pressures were higher, and aldosterone was lower in participants with past APOs. Associations of aldosterone with APO history persisted after adjustment. Neither renin nor aldosterone were related to vascular function. Adverse pregnancy outcomes (APOs) are associated with cardiovascular disease (CVD) risk. Traditional CVD risk factors may not fully capture excess CVD risk soon after APOs. Vascular dysfunction and plasma volume irregularities may be detectable. We found people with APOs had worse blood pressures, higher BMI, and lower aldosterone levels versus those without APOs in the early years after delivery. Vascular function was similar between groups. Future research should assess vascular function and renal hormones at multiple timepoints during the perinatal period.

References
1.
Vaidya A, Sun B, Larson C, Forman J, Williams J . Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab. 2012; 97(7):2456-65. PMC: 3387405. DOI: 10.1210/jc.2012-1156. View

2.
Godin G, Shephard R . A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985; 10(3):141-6. View

3.
Lane-Cordova A, Bouknight S . Importance of Sensitive Vascular Measurements for Evaluating Effects of Lifestyle in Premenopausal Women. Front Cardiovasc Med. 2020; 7:575908. PMC: 7550521. DOI: 10.3389/fcvm.2020.575908. View

4.
Brown J, Underwood P, Ferri C, Hopkins P, Williams G, Adler G . Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk. Hypertension. 2014; 63(6):1205-11. PMC: 4016103. DOI: 10.1161/HYPERTENSIONAHA.114.03231. View

5.
Lane A, Whitaker K, Tahir M, Gibbs B, Catov J, Carnethon M . Associations of Physical Activity and Lactation Duration With Cardiometabolic Risk Factors: The CARDIA Study. JACC Adv. 2023; 2(4). PMC: 10426753. DOI: 10.1016/j.jacadv.2023.100378. View